FRIDAY, Jan. 6, 2023 (HealthDay News) The U.S. Food and Drug Administration on Friday approved a second Alzheimer s drug, lecanemab, despite reports of rare brain bleeds linked to use
FRIDAY, Jan. 6, 2023 (HealthDay News) The U.S. Food and Drug Administration on Friday approved a second drug for Alzheimer disease, Leqembi (lecanemab-irmb), despite reports of rare brain bleeds
FRIDAY, Jan. 6, 2023 (HealthDay News) The U.S. Food and Drug Administration on Friday approved a second Alzheimer s drug, lecanemab, despite reports of rare brain bleeds linked to use
THURSDAY, Jan. 5, 2023 (HealthDay News) Lecanemab: It s an experimental medication that s been shown in trials to slow cognitive decline in people with Alzheimer’s disease.
FRIDAY, Jan. 6, 2023 (HealthDay News) The U.S. Food and Drug Administration on Friday approved a second Alzheimer s drug, lecanemab, despite reports of rare brain bleeds linked to use